Erysipelas bullous

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 18.12.2020

Dieser Artikel auf Deutsch

Synonym(s)

Bullous erysipelas; Erysipelas vesiculosum et bullosum

Definition
This section has been translated automatically.

Acute, severe, bacterial, vesicular and blistering local infection of the lymphatic clefts and lymph vessels of the dermis, accompanied by localized painful redness and swelling, with general symptoms such as malaise, fever, chills and painful lymphadenitis.

Etiopathogenesis
This section has been translated automatically.

See below Erysipelas. Blistering erysipelas occurs preferentially in immunosuppressed patients, in obese patients or in patients with chronic venous insufficiency(CVI), possibly combined with an arterial circulatory disorder(PAOD).

Localization
This section has been translated automatically.

Mostly the lower legs are affected.

Clinical features
This section has been translated automatically.

Incubation period: 1-3 days.

Integument: Beginning with an asymmetrical, mostly from a small injury (erysipelas), fiery red, painful, sharply defined erythema or plaque. Fever and chills may precede or accompany the process (Note: afebrile erysipelas may be observed under therapy with Etanercept ). Rapid continuous migration of the painful redness, which often has a flame-like lateral or proximal border. Formation of mostly haemorrhagic blisters, which may merge into larger "bladder lakes".

General symptoms: The process is accompanied by feelings of tension and heat, pain, oedema, fever (up to 40 °C) and chills. Painful regional lymphadenitis (constant sign of acute infection).

Therapy
This section has been translated automatically.

Literature
This section has been translated automatically.

  1. Del Giudice P et al (2007) Bullous erysipelas caused by community-acquiredmethicillin-resistant Staphylococcus aureus. Dermatology 214:191-192
  2. Krasagakis K et al (2011) Local complications of erysipelas: a study of associated risk factors. Clin Exp Dermatol 36:351-454
  3. Linke M et al (2015) Risk factors associated with a reduced response in thetreatment of erysipelas. J Dtsch Dermatol Ges 13:217-225
  4. Titou H et al (2017) Risk factors associated with localcomplications of erysipelas: a retrospective study of 152 cases. Pan Afr Med J 26:66.


Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 18.12.2020